Company Overview of Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, designs and develops insulin-based therapies for the treatment of diabetes in the United States. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals, Inc. was founded in 2004 and is based in Cleveland, Ohio.
10000 Cedar Avenue
Cleveland, OH 44106
Founded in 2004
Key Executives for Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Praetego, Inc.||United States|
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
July 5, 2017
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Diasome Pharmaceuticals, Inc., please visit www.diasome.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.